In 2019, a novel, highly contagious coronavirus that caused respiratory illness began to spread globally,…
pthomsonNovember 2, 2021
Dr. Jacobson’s and Dr. Vallance’s labs are focusing on the role of the epithelial barrier…
pthomsonNovember 2, 2021
Dr. Anna Blakney (pictured), an Assistant Professor at UBC, was awarded a Canadian Institutes of…
pthomsonNovember 1, 2021
NervGen Pharma Corp. (TSX-V: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a clinical stage biotech…
pthomsonNovember 1, 2021
It has been a prolific quarter for TFRI’s BC-based lymphoma research team. In the span…
pthomsonOctober 29, 2021
TFRI-funded researchers at BC Cancer in a new study demonstrate that a genomic test known…
pthomsonOctober 28, 2021
Dr. Webb, the McLeod Professor of Heart Valve Innovation at UBC, has received the 2021…
pthomsonOctober 28, 2021
Zymeworks Inc. (“Zymeworks”), a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of…
sciencecityApril 21, 2017
Cellular Dynamics International (CDI), a FUJIFILM company and a leading developer and manufacturer of induced…
sciencecityApril 19, 2017
Less than a year after publishing research identifying a single genetic mutation that caused multiple…
sciencecityApril 18, 2017
Aiden Gibbons was three days old when doctors noticed he was missing something most people…
sciencecityApril 14, 2017
The power of environmental DNA (eDNA) is just being tapped. Field surveys to determine if…
sciencecityApril 13, 2017
SFU researchers have created a patent-pending, optical diagnostic probe capable of more safely and non-invasively…
sciencecityApril 12, 2017
By the time a person with Parkinson’s disease (PD) receives a diagnosis, they have already…
sciencecityApril 11, 2017
A record amount of money is spent developing new drugs, but drug approval rates are…
sciencecityApril 11, 2017
